Pharmacokinetics of mitomycin C after resection of peritoneal carcinomatosis and intraperitoneal chemohyperthermic perfusion

Journal of Chemotherapy

Volumn 17, Issue 6, 2005, Pages 668-673

  Cerretani, D ^a   Nencini, C ^a   Urso, R ^a   Giorgi, G ^a   Marrelli, D ^a   De Stefano, A ^a   Pinto, E ^a   Cioppa, T ^a   Nastri, G ^a   Roviello, Franco ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

Intraperitoneal chemohyperthermic perfusion; Mitomycin C; Pharmacokinetics

Indexed keywords

MITOMYCIN C;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CANCER RECURRENCE; CANCER SURGERY; CARCINOMATOUS PERITONITIS; CLINICAL ARTICLE; COMPARTMENT MODEL; CYTOREDUCTIVE SURGERY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG HALF LIFE; DRUG URINE LEVEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERTHERMIC THERAPY; INFUSION PUMP; INTRAPERITONEAL CHEMOHYPERTHERMIC PERFUSION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; METASTASIS; ULTRAVIOLET HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; URINALYSIS;

EID: 30744452465     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2005.17.6.668     Document Type: Article

References (13)

1. Markman M. Intraperitoneal chemotherapy in the management of colon cancer. Semin Oncol 1999; 26 (2): 536-539.
2. Spratt JS, Adcock RA, Muskovin M, Sherrill W, McKeown J. Clinical delivery system for intraperitoneal hyperthermic chemotherapy. Cancer Res 1980; 40 (2): 256-260.
3. Ceelen WP, Hesse U, de Hemptinne B, Pattyn P. Hyperthermic intraperitoneal chemoperfusion in the treatment of locally advanced intra-abdominal cancer. Br J Surg 2000; 87 (8): 1006-1015.
4. Gilly FN, Beaujard A, Glehen O et al. Peritonectomy combined with intraperitoneal chemohyperthermia in abdominal cancer with peritoneal carcinomatosis: phase I-II study. Anticancer Res 1999; 19 (3B): 2317-2321.
5. Sugarbaker PH, Cunliffe W, Belliveu J et al. Rationale for early postoperative intraperitoneal chemotherapy as a surgical adjuvant for gastrointestinal malignancy. Reg Canc Treat 1989; 1: 66-79.
6. Beujard AC, Glehen O, Caillot JL et al. Intraperitoneal chemohyperthermia with mitomycin C for digestive tract cancer patients with peritoneal carcinomatosis. Cancer 2000; 88 (11): 2512-2519.
7. Sugarbaker PH, Cunliffe W, Belliveu J et al. Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer. Semin Oncol 1989; 16: 83-97.
8. Witkamp AJ, de Bree E, Van Goethem R, Zoetmulder FA. Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy. Cancer Treat Rev 2001; 27 (6): 365-374.
9. Keller E, Reetze P, Schollmeyer P. Drug therapy in patients undergoing continues ambulatory peritoneal dialysis. Clinical pharmacokinetic considerations. Clin Pharmacokinet 1990; 18 (2): 104-117.
10. Paroni R, Arcelloni C, De Vecchi E, Fermo I, Mauri D, Colombo R. Plasma mitomycin C concentrations determined by HPLC coupled to solid-phase extraction. Clin Chem 1997; 43 (4): 615-18.
11. de Lima Vazquez V, Stuart OA, Mohamed F, Sugarbaker PH. Extent of parietal peritonectomy does not change intraperitoneal chemotherapy pharmacokinetics. Cancer Chemother Pharmacol. 2003; 52(2): 108-12.
12. van Ruth S, Mathot RA, Sparidans RW, Beijnen JH, Verwaal VJ, Zoetmulder FA. Population pharmacokinetics and pharmacodynamics of mitomycin during intraoperative hyperthermic intraperitoneal chemotherapy. Clin Pharmacokinet. 2004; 43(2): 131-43.
13. den Hartigh J, Mc Vie JG, van Ourt WJ, Pinedo MH. Pharmacokinetics of mitomycin C in humans. Cancer Res 1982; 43: 5017-5021.